A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib

• Status: Completed
• Trial end date: 2015-04-01

Summary

This study will investigate whether concurrent administration of rabeprazole, an antacid known as a proton pump inhibitor, alters the absorption of the drug palbociclib when given as one of six experimental formulations.

• Phase: Phase 1

Details

• Lead Sponsor: Pfizer
• Treatments: Antacids; Palbociclib; Proton Pump Inhibitors; Rabeprazole